Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by MirrorWorldManon Oct 06, 2021 11:52am
187 Views
Post# 33973630

RE:RE:News .....

RE:RE:News ..... After many promising NR's and costly efforts regarding chinese distributors, it looks like Howie cancelled trying to make a deal with any of them (again). This time he blames the changing regulations. So much for offering a skin lightening panacea to that huge market he keeps pointing at, he will let the (potential) super new global partner handle all that. More discussions with them first though. Moving on, Wannabang has not even provides easy to assemble Phase 1 results and now howie trusts them to make the a SGLT2 for cats? What happened to that transparent regular communication updates from WannaBang that was promised by Howie? Our CEO is being played as a fool. Oh yeah, Merck already is finishing their anitViral and we haven't even started ours yet-we halted research a few months ago but let's talk about it anyway. The anti-aging thing- its been so long now that those arctic fish will be extinct before Howie moves on that and the boomers that need it will be 6 feet under. Lose our CEO and get someone who had business skills. 
<< Previous
Bullboard Posts
Next >>